Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children
- 1 June 2000
- Vol. 18 (24) , 2656-2660
- https://doi.org/10.1016/s0264-410x(00)00062-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adultsVaccine, 1999
- Seroprevalencia de anticuerpos bactericidas frente al meningococo C en Cantabria 10 meses tras la campaña de vacunaciónRevista Espanola de Salud Publica, 1998
- Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom InfantsThe Journal of Infectious Diseases, 1996
- Analysis of Meningococcal Serogroup C-Specific Antibody Levels in British Columbian Children and AdolescentsThe Journal of Infectious Diseases, 1996
- Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among childrenThe Journal of Pediatrics, 1996
- Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech RepublicEpidemiology and Infection, 1995
- A Trial Of A Group A Plus Group C Meningococcal Polysaccharide-ProteinThe Journal of Infectious Diseases, 1995
- Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccinationVaccine, 1993
- Reactogenicity and Immunogenicity of a Quadrivalent Combined Meningococcal Polysaccharide Vaccine in ChildrenThe Journal of Infectious Diseases, 1986
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969